Close Menu

More articles about Business News

The company's common stock is now traded on the Over-The-Counter Bulletin Board.

Although the suit was first filed last summer, the courtroom showdown had been brewing for years.

The FTC provided provisional approval of Danaher's purchase of MDS Analytical Technologies. However, it is requiring MDS to sell its laser microdissection business to Life Technologies to alleviate the agency's competition concerns.

The joint venture in the Dallas area will offer clinical lab services, molecular diagnostics, and pharmacogenomic tests and will focus on cancer.

The agro-tech company will use Fluidigm's tools under a global agreement in its field and vegetable plant programs.

PerkinElmer withdrew the patent infringement suit only a week after filing it.

The firm has partnered with Cold Spring Biotech, Pharmatech, and Research Instruments.

The agreement settles a suit brought in Canada last month by PerkinElmer against MDS, seeking to block the transfer of a joint venture with MDS Analytical Technologies to Danaher.

The suit relates to mass spectrometry patents held by PerkinElmer and comes a month after the firm filed a separate action against MDS in Canada.

The firm has emerged from bankruptcy protection only 10 months after filing for Chapter 11.

The Canadian proteomics company bought the unit to strengthen its position in the biomarker services market.

The investment bank maintained its 12-month price targets on the respective stocks. It said that Genomic Health was trading at an "attractive entry point."

Patents awarded to Samsung Electronics, Micronics, Sanofi-Pasteur, and Gen-Probe

Med BioGene said that the purpose of the rights plan is to provide sufficient time to its board and shareholders to assess any unsolicited takeover bids.

The IVD developer has licensed two protein markers for diabetes that were developed with NIH funds in partnership with Yale.

The patent, DE 10066235, was granted in January 2008, and covers methods, uses, and medicaments of siRNAs, with a length between 15 and 49 nucleotides, expressed through a vector, according to Alnylam.

The IP fell under USPTO scrutiny as part of a protracted patent-infringement battle Benitec waged with now-defunct expressed RNAi shop Nucleonics.

"By adopting a more accessible approach to intellectual property, the pool facilitates access to compounds and technologies and, most importantly, industrial know-how for organizations that want to conduct research on treatments for these neglected diseases," the companies said.

IP Update: Jan 21, 2010


USPTO Publishes Three Patents, Twenty One Patent Applications Related to RNAi

The Spanish firm will distribute DiaGenic's Alzheimer's test in Europe and Latin America.


The Washington Post writes that the approval in the US of a SARS-CoV-2 vaccine will be up to Peter Marks, a career official at the Food and Drug Administration.

According to ScienceInsider, the US National Academies of Science, Engineering, and Medicine is planning a study of racism in academic research.

NPR reports the US loan to Eastman Kodak to boost domestic pharmaceutical production is on pause following insider trading allegations.

In Cell this week: blood immune cell changes in COVID-19 patients and spatial transcriptomics in Alzheimer's disease.